GHK-Cu fits into this trend by offering: At-home use under medical guidance Formulations developed by licensed compounding pharmacies Personalization based on individual appearance goals These programs are not intended to treat any health condition but may support cosmetic improvements in skin and hair
Instead, Klinic offers telehealth-based weight management through Wegovy, Oral Wegovy, Zepbound, and Foundayo, all supported by an insurance-friendly framework
These medicines include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and others
Clinical trials end at week 48, but treatment decisions continue
Consult your doctor for personalized guidance.
While the risk of yeast infections is not directly linked to semaglutide, those with diabetes may face increased susceptibility due to uncontrolled blood sugar levels